SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/D71C4096D8874A7EAA2B814C55B7A8F7E8C5ED3EF87F0B79CA2ADF2BBB28BEF0DC3222B57A7AB97F68383D5C686B2711>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/D71C4096D8874A7EAA2B814C55B7A8F7E8C5ED3EF87F0B79CA2ADF2BBB28BEF0DC3222B57A7AB97F68383D5C686B2711
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/D71C4096D8874A7EAA2B814C55B7A8F7E8C5ED3EF87F0B79CA2ADF2BBB28BEF0DC3222B57A7AB97F68383D5C686B2711
http://www.w3.org/2000/01/rdf-schema#comment
"Data show that microRNA miR-379 potentiated lung cancer (LCa) chemosensitivity via modulation of cisplatin (CDDP)-induced apoptosis by directly targeting the eukaryotic translation initiation factor 4 gamma 2 (EIF4G2) 3' UTR."
xsd:string
http://purl.uniprot.org/uniprot/#_323F83912241829F1758AEA3BAF5CE6508C1544860D9CB6979E76969222D6A6AA3DED118DB60AA4034C6E5165E9224EF
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/D71C4096D8874A7EAA2B814C55B7A8F7E8C5ED3EF87F0B79CA2ADF2BBB28BEF0DC3222B57A7AB97F68383D5C686B2711
http://purl.uniprot.org/uniprot/D3DQV9
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/D71C4096D8874A7EAA2B814C55B7A8F7E8C5ED3EF87F0B79CA2ADF2BBB28BEF0DC3222B57A7AB97F68383D5C686B2711
http://purl.uniprot.org/uniprot/#_D3DQV9-mappedCitation-28117895
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/D71C4096D8874A7EAA2B814C55B7A8F7E8C5ED3EF87F0B79CA2ADF2BBB28BEF0DC3222B57A7AB97F68383D5C686B2711